Arkolith/Insider Trading/RVMD/Form 4

Mancini Anthony

See RemarksRevolution Medicines, Inc. (RVMD) · full profile →Form 4 · filed Apr 29, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$413K
Net Open-Market Flow
-$413K
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 27, 2026Option exercise(M)3K$33.62$105K58K
Apr 27, 2026Sell(S)2K$131.66$220K56K
Apr 27, 2026Sell(S)1K$132.88$139K55K
Apr 27, 2026Sell(S)400$134.34$54K54K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 27, 2026Option exercise(M)3K—$0109K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-26-000158) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML